Department: Biomedicina, Biotecnología y Salud Pública

Area: Biochemistry and Molecular Biology


Personal web:

I am a Junior Group Leader in the field of Liver Metabolic Research. We use a combination of disease models (our newly developed human liver chimeric mice, transgenic mice, and cellular systems), along with interdisciplinary approaches (physiological and metabolic studies in vivo, ex vivo biochemical analyses, and cutting-edge CRISPR/Cas9 liver-targeted genome engineering) to identify relevant pathways involved in the progression of non-alcoholic fatty liver disease (NAFLD) and to manipulate these pathways in order to mitigate the disease.